Represented DuPont in "settlement fraud" case alleging federal RICO, fraud and other state law claims arising out of DuPont's alleged fraudulent inducement of hundreds of settlements of product liability claims in the early 1990s. Between 1996 and 2000, approximately 70 plaintiffs asserted "settlement fraud" claims against DuPont in the United States District Court for the District of Hawaii or in Hawaii state court, and DuPont asserted claims in federal court for breach of the settlement agreement. Ultimately, all of the federal cases were consolidated under the Matsuura case style. DuPont originally prevailed in the district court on motions to dismiss the "settlement fraud" claims based on provisions in the settlement agreements. When those rulings were superseded by a ruling of the Delaware Supreme Court, DuPont filed motions for judgment on the pleadings which led to a certified question proceeding before the Hawaii Supreme Court. After the Hawaii Supreme Court ruled, the District Court granted a number of dispositive motions filed by DuPont, as did the Hawaii state court in a related case. During the pendency of appeals from those decisions, the vast majority of the Hawaii claimants settled. Similar dispositions results in Florida and Georgia litigations.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Investigation by DOJ of whistleblower claims
In less than four months, convinced the Civil Division of the Department of Justice that a whistleblower’s claims against a company did not merit the more
Design, construction, and commissioning of an off-shore oil production facility in Malaysia for worldwide oil and gas organization
Represent a worldwide oil and gas organization with respect to disputes against various EPC contractors retained to perform the design, more
Taurus IP LLC v. Chrysler Group and Mercedes-Benz USA LLC
The firm served as lead counsel on behalf of Chrysler Group and Mercedes-Benz USA LLC in connection with a string of successes in the more
Acquisition by pharmaceutical company
Represented pharmaceutical company before the Federal Trade Commission in connection with antitrust merger review.  Advised pharmaceutical company on more